Zevra Therapeutics, Inc.
ZVRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434647
In the last 90 days, Zevra Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $642.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Zevra Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +16 vs. Q2 2024
- Shares held
- 29.0M
- +15.6M (+117.0%) vs. Q2 2024
- Total value
- $201.0M
- +$135.7M (+207.6%) vs. Q2 2024
- New holders
- 28
- 37 more added
- Sold out
- 12
- 19 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZVRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $642.0M |
| Q1 2026 | 148 | $384.6M |
| Q4 2025 | 159 | $341.8M |
| Q3 2025 | 166 | $379.4M |
| Q2 2025 | 121 | $318.9M |
| Q1 2025 | 111 | $264.9M |
| Q4 2024 | 110 | $282.9M |
| Q3 2024 | 108 | $201.0M |
| Q2 2024 | 93 | $78.6M |
| Q1 2024 | 89 | $80.7M |
| Q4 2023 | 84 | $83.0M |
| Q3 2023 | 77 | $52.1M |
| Q2 2023 | 71 | $41.6M |
| Q1 2023 | 61 | $33.8M |
| Q4 2022 | 70 | $27.2M |
| Q3 2022 | 69 | $41.8M |
| Q2 2022 | 73 | $32.4M |
| Q1 2022 | 82 | $45.4M |
| Q4 2021 | 76 | $63.3M |
| Q3 2021 | 70 | $73.1M |
| Q2 2021 | 70 | $98.3M |
| Q1 2021 | 51 | $21.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Zevra Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 683 Capital Management, LLC | 1,225,000 | $8.50M | 0.87% | +425,000+53.1% | Added |
| Altium Capital Management LP | 1,700,000 | $11.8M | 3.51% | +537,584+46.2% | Added |
| FMR LLC | 2,313,202 | $16.1M | 0.00% | +2,312,384+282,687.5% | Added |
| Vanguard Group Inc | 2,756,061 | $19.1M | 0.00% | +922,646+50.3% | Added |
| Nantahala Capital Management, LLC | 2,924,021 | $20.3M | 1.71% | +504,586+20.9% | Added |
| BlackRock, Inc. | 3,121,759 | $21.7M | 0.00% | +3,121,759 | New |
| Woodline Partners LP | 4,048,653 | $28.1M | 0.24% | +2,901,070+252.8% | Added |
| International Assets Investment Management, LLC | 6,940 | – | – | +5,940+594.0% | Added |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −181,673−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −112,800−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −91,118−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −39,764−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −28,272−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −18,402−100.0% | Sold out |
| Palumbo Wealth Management LLC | 0 | $0 | 0.00% | −12,902−100.0% | Sold out |
| Measured Wealth Private Client Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −4,871−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| VisionPoint Advisory Group, LLC | 0 | $0 | 0.00% | −1,730−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |